TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
BiolacUm AB
Closing information (x1000 NOK)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
406
|
609 | |
| Financial expenses |
0
|
2,533 | |
| Earnings before taxes |
2,228
|
-2,278 | |
| EBITDA |
157
|
249 | |
| Total assets |
7,616
|
5,355 | |
| Current assets |
664
|
606 | |
| Current liabilities |
64
|
50 | |
| Equity capital |
7,378
|
5,096 | |
| - share capital |
103
|
101 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
96.9%
|
95.2% | |
| Turnover per employee |
406
|
609 | |
| Profit as a percentage of turnover |
548.8%
|
-374.1% | |
| Return on assets (ROA) |
29.3%
|
4.8% | |
| Current ratio |
1037.5%
|
1212.0% | |
| Return on equity (ROE) |
30.2%
|
-44.7% | |
| Change turnover |
-213
|
-236 | |
| Change turnover % |
-5%
|
-34%
|
-28% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.